PHASE 1 STUDY: SAFETY AND TOLERABILITY OF INCREASING DOSES OF CB-839, AN ORALLY-ADMINISTERED SMALL MOLECULE INHIBITOR OF GLUTAMINASE, IN ACUTE LEUKEMIA
HAEMATOLOGICA（2015）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined